| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.00033 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.00035 | 1 |